PET/CT in primary hepatic lymphoma with hepatic vein thrombus that extended into the inferior vena cava.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Primary hepatic lymphoma (PHL) is an extremely rare manifestation of extranodal non-Hodgkin's lymphoma (0.016% of all cases). Presented are CT, MRI, ultrasound, and (18)F fluoro-2-deoxy-D-glucose (FDG) PET/CT images, which characterized PHL and demonstrated hepatic vein thrombus that extended into the inferior vena cava--a feature not previously described. Recognition of this imaging pattern may help in the differential diagnosis of future such cases. FDG PET/CT was critical in confirming the diagnosis, staging, and demonstrating response to treatment.

Original languageEnglish (US)
Pages (from-to)153-156
Number of pages4
JournalClinical Nuclear Medicine
Volume38
Issue number2
StatePublished - Feb 1 2013

Fingerprint

Hepatic Veins
Deoxyglucose
Inferior Vena Cava
Lymphoma
Thrombosis
Liver
Non-Hodgkin's Lymphoma
Differential Diagnosis

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{5207671cd2224d8ba754bdf9c8970e3b,
title = "PET/CT in primary hepatic lymphoma with hepatic vein thrombus that extended into the inferior vena cava.",
abstract = "Primary hepatic lymphoma (PHL) is an extremely rare manifestation of extranodal non-Hodgkin's lymphoma (0.016{\%} of all cases). Presented are CT, MRI, ultrasound, and (18)F fluoro-2-deoxy-D-glucose (FDG) PET/CT images, which characterized PHL and demonstrated hepatic vein thrombus that extended into the inferior vena cava--a feature not previously described. Recognition of this imaging pattern may help in the differential diagnosis of future such cases. FDG PET/CT was critical in confirming the diagnosis, staging, and demonstrating response to treatment.",
author = "Kevin Diehl and Nabeel Sarwani and Mark Tulchinsky",
year = "2013",
month = "2",
day = "1",
language = "English (US)",
volume = "38",
pages = "153--156",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

PET/CT in primary hepatic lymphoma with hepatic vein thrombus that extended into the inferior vena cava. / Diehl, Kevin; Sarwani, Nabeel; Tulchinsky, Mark.

In: Clinical Nuclear Medicine, Vol. 38, No. 2, 01.02.2013, p. 153-156.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PET/CT in primary hepatic lymphoma with hepatic vein thrombus that extended into the inferior vena cava.

AU - Diehl, Kevin

AU - Sarwani, Nabeel

AU - Tulchinsky, Mark

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Primary hepatic lymphoma (PHL) is an extremely rare manifestation of extranodal non-Hodgkin's lymphoma (0.016% of all cases). Presented are CT, MRI, ultrasound, and (18)F fluoro-2-deoxy-D-glucose (FDG) PET/CT images, which characterized PHL and demonstrated hepatic vein thrombus that extended into the inferior vena cava--a feature not previously described. Recognition of this imaging pattern may help in the differential diagnosis of future such cases. FDG PET/CT was critical in confirming the diagnosis, staging, and demonstrating response to treatment.

AB - Primary hepatic lymphoma (PHL) is an extremely rare manifestation of extranodal non-Hodgkin's lymphoma (0.016% of all cases). Presented are CT, MRI, ultrasound, and (18)F fluoro-2-deoxy-D-glucose (FDG) PET/CT images, which characterized PHL and demonstrated hepatic vein thrombus that extended into the inferior vena cava--a feature not previously described. Recognition of this imaging pattern may help in the differential diagnosis of future such cases. FDG PET/CT was critical in confirming the diagnosis, staging, and demonstrating response to treatment.

UR - http://www.scopus.com/inward/record.url?scp=84879339980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879339980&partnerID=8YFLogxK

M3 - Article

C2 - 23334136

AN - SCOPUS:84879339980

VL - 38

SP - 153

EP - 156

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -